Core Insights - The Chinese health technology market is attracting multinational giants due to its large scale and promising prospects, with Intuitive Surgical actively expanding its presence through a "local manufacturing + talent cultivation" dual-driven model [1][2] Company Overview - Intuitive Surgical established a joint venture with Fosun Pharma in 2017, named Intuitive Fosun, to penetrate the Chinese market [1] - The Intuitive Fosun Innovation Center, inaugurated in 2021 in Shanghai, is the first international standard surgical robot training base in China, enabling local doctors to receive training without going abroad [1] - The new headquarters in Shanghai, set to open in June 2024, will have an investment exceeding 700 million yuan and cover an area of over 45,000 square meters, serving as the largest integrated R&D, production, and training base for Intuitive Surgical in the Asia-Pacific region [1] Talent Development - The training capabilities of the Intuitive Fosun Innovation Center have been upgraded, with the Da Vinci training curriculum receiving accreditation from the Royal College of Surgeons (RCS) in 2022, making it the first surgical robot company in China to offer such internationally recognized courses [2] - The center has developed an immersive teaching system covering various surgical specialties, providing personalized courses from basic operations to complex surgeries, enhancing the professional skills of over 6,300 surgical healthcare professionals [2] - Intuitive Fosun collaborates with over 20 top-tier hospitals to establish "Da Vinci Surgical Robot Training Teaching Centers," creating a "medical-education integration" training system [2] Strategic Vision - The CEO of Intuitive Fosun, Dr. Liu Fu-jun, emphasized the importance of a collaborative innovation model involving hospitals, enterprises, and regulators to create a complete feedback loop from technical training to professional education and clinical application [2] - The company is entering a new phase of "local manufacturing" and "talent cultivation," aiming to accelerate the clinical transformation of cutting-edge technologies to benefit more local patients [2]